Evaluation of surgical and non-surgical periodontal therapies, and immunological status, of young Down's syndrome patients.

BACKGROUND Individuals with Down's syndrome (DS) differ in their oral condition compared with the healthy population. Periodontal disease in persons with DS under the age of 30 years is very high. Immune deficiencies are also present. For dental practitioners it is difficult to decide on a particular course of treatment. In this study, patients with DS were selected in order to 1) evaluate the effectiveness of surgical and non-surgical periodontal therapies and 2) assess their immunological status. METHODS The population consisted of 14 DS patients (14 to 30 years old). Surgical and non-surgical periodontal therapies were compared in a split-mouth design. Clinical measurements of plaque index (PI), gingival index (GI), probing depth (PD), and clinical attachment levels (CAL) were taken at baseline, posttreatment, 6 months, and 1 year. Immunomodulatory activity of neutrophils was analyzed in vitro by chemotaxis (Boyden migration chamber), phagocytic activity, and production of super-oxide anion (NBT reduction) tests and compared between DS patients and healthy controls. RESULTS Both surgical and non-surgical therapies showed a significant improvement in all the clinical parameters compared to baseline. There were no differences between surgical and nonsurgical therapy in PI or GI. There was a significant PD reduction with the non-surgical therapy at 1 to 3 mm PD. However in PD >3 mm the surgical therapy, although not statistically significant, showed better results. Neutrophil chemotaxis, phagocytic activity, and production of super-oxide anion were significantly decreased in the DS patients. CONCLUSIONS After a year, both surgical and non-surgical therapies have similar periodontal clinical improvement in DS patients. There is partial impairment of immunological functions in DS individuals which does not seem to affect the clinical response to therapy.

[1]  I Needleman,et al.  A systematic review of the effect of surgical debridement vs non-surgical debridement for the treatment of chronic periodontitis. , 2002, Journal of clinical periodontology.

[2]  C. Douglass,et al.  Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. , 2002, Journal of clinical periodontology.

[3]  M. Nunn,et al.  Longitudinal comparison of the periodontal status of patients with moderate to severe periodontal disease receiving no treatment, non-surgical treatment, and surgical treatment utilizing individual sites for analysis. , 2001, Journal of periodontology.

[4]  J. Fiske,et al.  Down's syndrome and oral care. , 2001, Dental update.

[5]  S. Hamada,et al.  Relationship of periodontopathic bacteria with early-onset periodontitis in Down's syndrome. , 2001, Journal of periodontology.

[6]  R. Caffesse,et al.  A longitudinal study comparing scaling, osseous surgery, and modified Widman procedures: results after 5 years. , 1988, Journal of periodontology.

[7]  P. Mehta,et al.  Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. , 2000, Clinical Immunology.

[8]  A. Munshi,et al.  Neutrophil chemotaxis in Down syndrome and normal children to Actinobacillus actinomycetemcomitans. , 1998, The Journal of clinical pediatric dentistry.

[9]  D. Lopatin,et al.  The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome. , 1997, Journal of periodontology.

[10]  K. Patil,et al.  Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. , 1996, Journal of periodontology.

[11]  E. Novo,et al.  Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells. , 1993, American journal of medical genetics.

[12]  O. Sanal,et al.  Neutrophil chemotaxis and periodontal status in Down's syndrome patients. , 1993, The Journal of Nihon University School of Dentistry.

[13]  K. Kalkwarf,et al.  A review of longitudinal studies that compared periodontal therapies. , 1993, Journal of periodontology.

[14]  T. Modéer,et al.  Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. , 1992, Oral microbiology and immunology.

[15]  F. Licastro,et al.  Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. , 2005, American journal of medical genetics. Supplement.

[16]  L. Notarangelo,et al.  Immunology of Down syndrome: a review. , 2005, American journal of medical genetics. Supplement.

[17]  Y. Izumi,et al.  Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. , 1989, Journal of periodontology.

[18]  Rascón Trincado Mv,et al.  A study of the functions of polymorphonuclear neutrophil in patients with Down's syndrome. , 1988 .

[19]  R. Caffesse,et al.  A longitudinal study comparing scaling, osseous surgery and modified Widman procedures. Results after one year. , 1988, Journal of periodontology.

[20]  J. S. van de Gevel,et al.  Nonspecific and specific immune responses in a child with Down's syndrome and her sibling. A case report. , 1988, Journal of periodontology.

[21]  R. Caffesse,et al.  4 modalities of periodontal treatment compared over 5 years. , 1987, Journal of clinical periodontology.

[22]  R. Caffesse,et al.  Four modalities of periodontal treatment compared over five years. , 1987, Journal of periodontal research.

[23]  R. Caffesse,et al.  Scaling and root planing with and without periodontal flap surgery. , 1986, Journal of clinical periodontology.

[24]  W. Reuland-Bosma,et al.  Periodontal disease in Down's syndrome: a review. , 1986, Journal of clinical periodontology.

[25]  R. Attström,et al.  The effect of root planing as compared to that of surgical treatment. , 1984, Journal of clinical periodontology.

[26]  G. Annéren,et al.  Low Superoxide Levels in Blood Phagocytic Cells in Down's Syndrome , 1984, Acta paediatrica Scandinavica.

[27]  R. McHugh,et al.  Comparison of surgical and nonsurgical treatment of periodontal disease. A review of current studies and additional results after 61/2 years. , 1983, Journal of clinical periodontology.

[28]  R. Caffesse,et al.  Four types of periodontal treatment compared over two years. , 1981, Journal of periodontology.

[29]  W. Weston,et al.  Phagocytic function in Down syndrome--I. Chemotaxis. , 2008, Journal of mental deficiency research.

[30]  W. Weston,et al.  Phagocytic function in Down syndrome--II. Bactericidal activity and phagocytosis. , 2008, Journal of mental deficiency research.

[31]  H Löe,et al.  The Gingival Index, the Plaque Index and the Retention Index Systems. , 1967, Journal of periodontology.

[32]  H. Löe,et al.  PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. , 1963, Acta odontologica Scandinavica.

[33]  J. Lejeune,et al.  [Study of somatic chromosomes from 9 mongoloid children]. , 1959, Comptes rendus hebdomadaires des seances de l'Academie des sciences.